Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Long-Term Investments (2016 - 2023)

Historic Long-Term Investments for BioCorRx (BICX) over the last 11 years, with Q2 2023 value amounting to $44520.0.

  • BioCorRx's Long-Term Investments changed 0.0% to $44520.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $44520.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $44520.0 for FY2022, which is 0.0% changed from last year.
  • BioCorRx's Long-Term Investments amounted to $44520.0 in Q2 2023, which was down 0.0% from $44520.0 recorded in Q1 2023.
  • In the past 5 years, BioCorRx's Long-Term Investments registered a high of $53793.0 during Q3 2019, and its lowest value of $13422.0 during Q1 2019.
  • For the 5-year period, BioCorRx's Long-Term Investments averaged around $41292.7, with its median value being $44520.0 (2020).
  • In the last 5 years, BioCorRx's Long-Term Investments skyrocketed by 30078.23% in 2019 and then plummeted by 1723.83% in 2020.
  • BioCorRx's Long-Term Investments (Quarter) stood at $41936.0 in 2019, then rose by 6.16% to $44520.0 in 2020, then changed by 0.0% to $44520.0 in 2021, then changed by 0.0% to $44520.0 in 2022, then changed by 0.0% to $44520.0 in 2023.
  • Its Long-Term Investments was $44520.0 in Q2 2023, compared to $44520.0 in Q1 2023 and $44520.0 in Q4 2022.